Well there it is folks...the big BLT share dump driving the price down.
Printable View
Well there it is folks...the big BLT share dump driving the price down.
Rationale is that there's good support at 1.3c and only $133 worth on offer at 1.4c. So a purchase of 10,000 shares (about $140 worth) will see us back at 1.5c. There are lots of people wanting in on this prior to the next update, so I wouldn't be surprised to see it head a bit higher before then.
There's a lot of buying going on with all this selling. I wonder if we won't see an SSH after a while.
Depends how many others want to dump their SPP shares. Currently a nice 30% profit for less than two weeks on a $15k investment. You might see someone panic and offload theirs for a measly 20% gain.
Hold in tight but there may be a bit of turbulance while the overhang from the SPP plays out. Good news at the next announcement will sort that out.
A lot of the SPP uptake will be from long term holders. Some traders will have been in on the action, but remember that a lot of the recent price upsurge (and new people coming on board) was occuring AFTER the record date for the SPP. That said, it doesn't tak emuch to move this stock (either way) so if a few traders decide to bail it does impact th eshareprice (in the short term anyway). Conversely (and as we saw a couple of weeks ago) the stock can jump up in price very quickly, so if I was a trader, I'm not sure I'd want to take too much off the table lest I miss the next jump.
Is it just me, or was the article in today's ODT (and also printed in NZ Herald) way off the mark.
http://www.odt.co.nz/news/business/2...lion-good-blis
The article suggests that the capital raising only brought in $1.391m of a $4.5m target, and fell well beneath expectations. Very negative tone throughout.
They seemed to have missed the point that the SPP to shareholders was only targeting $1.5m, and other placements to NZPR, APP, Edinburgh had already brought in $2.33m.
So in total, the capital raising has achieved $3.721m so far - well within the target range of $3.5m-$4.5m.
This tells a very different story to the one in today's article.
In my mind, the reality is a much different story - a well-supported capital raising; a new plant just opened up to allow for expanded operations; increasing revenues; new major shareholders with connections into Asia and the Middle East (directors of one of the new investment companies include former Prime Minister Jenny Shipley and the chairman of the Dubai Chamber of Commerce); regulatory approvals in USA, China and Europe; a distribution arrangement with China's largest pharmaceutical distributor (who happen to be visiting Dunedin this month - there's a better story for them); a forecast for a maiden profit "in the foreseeable future".
Or did I misunderstand something?